Divided US FDA AdComm Backs Molnupiravir Authorization But Wants More Studies

 
• By Brenda Sandburg
Molnupiravir
US FDA advisory committee favors FDA authorization of Merck's molnupiravir • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers